NO138530C - Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater

Info

Publication number: NO138530C
Authority: NO; Norway
Prior art keywords: derivatives; preparation; therapeutic active; substituted pyrazolone; analogical procedure
Prior art date: 1973-04-17

Application number

NO741365A

Other languages

English (en)

Norwegian (no)

Other versions

NO741365L (no

NO138530B (no

Inventor

Eike Moeller

Karl Meng

Egbert Wehinger

Harald Horstmann

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1973-04-17

Filing date

1974-04-16

Publication date

1978-09-20

1973-04-17 Priority claimed from DE2319280A external-priority patent/DE2319280A1/de

1973-12-19 Priority claimed from DE2363139A external-priority patent/DE2363139A1/de

1974-04-16 Application filed by Bayer Ag filed Critical Bayer Ag

1974-10-18 Publication of NO741365L publication Critical patent/NO741365L/no

1978-05-12 Publication of NO138530B publication Critical patent/NO138530B/no

1978-09-20 Publication of NO138530C publication Critical patent/NO138530C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
- C07D231/24—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
- C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Catalysts (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

NO741365A 1973-04-17 1974-04-16 Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater NO138530C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE2319280A DE2319280A1 (de)	1973-04-17	1973-04-17	1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2363139A DE2363139A1 (de)	1973-12-19	1973-12-19	1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (3)

Publication Number	Publication Date
NO741365L NO741365L (no)	1974-10-18
NO138530B NO138530B (no)	1978-05-12
NO138530C true NO138530C (no)	1978-09-20

Family

ID=25764996

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO741365A NO138530C (no)	1973-04-17	1974-04-16	Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater

Country Status (27)

Country	Link
US (1)	US3957814A (ro)
JP (1)	JPS5314071B2 (ro)
AR (5)	AR207444A1 (ro)
AT (1)	AT337176B (ro)
BG (5)	BG21857A3 (ro)
CA (1)	CA1034953A (ro)
CH (5)	CH605800A5 (ro)
DD (1)	DD113757A5 (ro)
DK (1)	DK136066C (ro)
EG (1)	EG11157A (ro)
ES (3)	ES425373A1 (ro)
FI (1)	FI57587C (ro)
FR (1)	FR2226172B1 (ro)
GB (1)	GB1429141A (ro)
HK (1)	HK70276A (ro)
HU (1)	HU168590B (ro)
IE (1)	IE39212B1 (ro)
IL (1)	IL44626A (ro)
LU (1)	LU69872A1 (ro)
NL (1)	NL177917C (ro)
NO (1)	NO138530C (ro)
PH (1)	PH14829A (ro)
PL (1)	PL96883B1 (ro)
RO (2)	RO69740A (ro)
SE (1)	SE408301B (ro)
SU (2)	SU539525A3 (ro)
YU (1)	YU104874A (ro)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4056533A (en) *	1973-04-17	1977-11-01	Bayer Aktiengesellschaft	Pyrazol-5-ones
DE2526467A1 (de) *	1975-06-13	1976-12-30	Bayer Ag	4-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3306366A1 (de) *	1983-02-24	1984-08-30	Bayer Ag, 5090 Leverkusen	Muzolimin enthaltende arzneimittel, deren verwendung und verfahren zu deren herstellung
US4663327A (en) *	1984-05-23	1987-05-05	Bayer Aktiengesellschaft	1-heteroaryl-4-aryl-pyrazolin-5-ones
JPH0730031B2 (ja) *	1986-04-02	1995-04-05	日産化学工業株式会社	２―ピラゾリン―５―オン類の製造法
DE3738963A1 (de) *	1987-11-17	1989-05-24	Bayer Ag	3-aminopyrazolin-5-one
GB8912861D0 (en) *	1989-06-05	1989-07-26	Sherritt Gordon Ltd	Purification of elemental sulphur
US5711929A (en) *	1989-05-06	1998-01-27	698638 Alberta Ltd.	Purification of elemental sulphur
JPH079410Y2 (ja) *	1989-05-08	1995-03-06	株式会社アンレット	炭酸ガスレーザー光線発振器用ルーツブロワー
US5399565A (en) *	1990-07-17	1995-03-21	Eli Lilly And Company	Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof
US5300514A (en) *	1990-07-17	1994-04-05	Eli Lilly And Company	Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof
DE69131268T2 (de) *	1990-09-21	1999-12-30	Rohm And Haas Co., Philadelphia	Dihydropyridazinone und Pyridazinone als Fungizide
CN1038249C (zh) *	1991-08-28	1998-05-06	罗姆和哈斯公司	含有二氢哒嗪酮及其相关化合物的杀菌组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2376380A (en) *		1945-05-22		Preparation of amino pyrazolones
GB636988A (en) *	1947-12-24	1950-05-10	Gevaert Photo Producten Naamlo	Improvements in and relating to the production of colour photographic images
US2511231A (en) *	1949-03-26	1950-06-13	Eastman Kodak Co	1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography
US2600788A (en) *	1949-06-07	1952-06-17	Eastman Kodak Co	Halogen-substituted pyrazolone couplers for color photography
US2672417A (en) *	1949-12-31	1954-03-16	Gevaert Photo Prod Nv	Production of color photographic images
NL279140A (ro) *	1961-05-31

1974
- 1974-01-01 AR AR253331A patent/AR207444A1/es active
- 1974-03-29 FR FR7411495A patent/FR2226172B1/fr not_active Expired
- 1974-04-09 HU HUBA3058A patent/HU168590B/hu unknown
- 1974-04-11 FI FI1105/74A patent/FI57587C/fi active
- 1974-04-12 BG BG027977A patent/BG21857A3/xx unknown
- 1974-04-12 IL IL44626A patent/IL44626A/xx unknown
- 1974-04-12 BG BG027979A patent/BG22821A3/xx unknown
- 1974-04-12 BG BG027978A patent/BG21218A3/xx unknown
- 1974-04-12 BG BG026395A patent/BG21217A3/xx unknown
- 1974-04-12 BG BG027980A patent/BG21405A3/xx unknown
- 1974-04-15 RO RO7485201A patent/RO69740A/ro unknown
- 1974-04-15 RO RO7400078420A patent/RO63749A/ro unknown
- 1974-04-15 PH PH15730A patent/PH14829A/en unknown
- 1974-04-15 JP JP4111274A patent/JPS5314071B2/ja not_active Expired
- 1974-04-15 US US05/461,282 patent/US3957814A/en not_active Expired - Lifetime
- 1974-04-15 DD DD177913A patent/DD113757A5/xx unknown
- 1974-04-15 YU YU01048/74A patent/YU104874A/xx unknown
- 1974-04-16 CH CH156577A patent/CH605800A5/xx not_active IP Right Cessation
- 1974-04-16 CH CH156677A patent/CH605797A5/xx not_active IP Right Cessation
- 1974-04-16 NO NO741365A patent/NO138530C/no unknown
- 1974-04-16 NL NLAANVRAGE7405115,A patent/NL177917C/xx not_active IP Right Cessation
- 1974-04-16 EG EG119/74A patent/EG11157A/xx active
- 1974-04-16 PL PL1974170378A patent/PL96883B1/pl unknown
- 1974-04-16 GB GB1650774A patent/GB1429141A/en not_active Expired
- 1974-04-16 CH CH156477A patent/CH605801A5/xx not_active IP Right Cessation
- 1974-04-16 DK DK208074A patent/DK136066C/da not_active IP Right Cessation
- 1974-04-16 CH CH156377A patent/CH596172A5/xx not_active IP Right Cessation
- 1974-04-16 CH CH524274A patent/CH603592A5/xx not_active IP Right Cessation
- 1974-04-16 LU LU69872A patent/LU69872A1/xx unknown
- 1974-04-16 ES ES425373A patent/ES425373A1/es not_active Expired
- 1974-04-16 SE SE7405078A patent/SE408301B/sv not_active IP Right Cessation
- 1974-04-16 AT AT313274A patent/AT337176B/de not_active IP Right Cessation
- 1974-04-17 IE IE798/74A patent/IE39212B1/xx unknown
- 1974-04-17 CA CA197,660A patent/CA1034953A/en not_active Expired
1975
- 1975-01-01 AR AR258508A patent/AR205272A1/es active
- 1975-01-01 AR AR258507A patent/AR205271A1/es active
- 1975-01-01 AR AR258506A patent/AR208192A1/es active
- 1975-03-19 SU SU2115103A patent/SU539525A3/ru active
- 1975-03-19 SU SU2114308A patent/SU541430A3/ru active
- 1975-04-25 AR AR258505A patent/AR204951A1/es active
1976
- 1976-04-15 ES ES447064A patent/ES447064A1/es not_active Expired
- 1976-04-15 ES ES447063A patent/ES447063A1/es not_active Expired
- 1976-11-11 HK HK702/76*UA patent/HK70276A/xx unknown

Also Published As

Publication number	Publication date
IE39212B1 (en)	1978-08-30
CH603592A5 (ro)	1978-08-31
US3957814A (en)	1976-05-18
AR205271A1 (es)	1976-04-21
NL177917B (nl)	1985-07-16
PH14829A (en)	1981-12-16
EG11157A (en)	1978-03-29
SU541430A3 (ru)	1976-12-30
BG21405A3 (bg)	1976-05-20
AR208192A1 (es)	1976-12-09
SE408301B (sv)	1979-06-05
DK136066C (da)	1978-01-16
ATA313274A (de)	1976-10-15
RO69740A (ro)	1982-09-09
BG21857A3 (bg)	1976-09-20
CH605797A5 (ro)	1978-10-13
IL44626A0 (en)	1974-06-30
ES447064A1 (es)	1977-09-16
YU104874A (en)	1982-02-28
CH605801A5 (ro)	1978-10-13
FR2226172B1 (ro)	1978-07-28
NO741365L (no)	1974-10-18
JPS5314071B2 (ro)	1978-05-15
IL44626A (en)	1980-01-31
CH596172A5 (ro)	1978-02-28
NL7405115A (ro)	1974-10-21
NO138530B (no)	1978-05-12
AU6817474A (en)	1975-10-23
AR205272A1 (es)	1976-04-21
FI57587C (fi)	1980-09-10
FI57587B (fi)	1980-05-30
JPS5018466A (ro)	1975-02-26
HU168590B (ro)	1976-06-28
AR207444A1 (es)	1976-10-08
IE39212L (en)	1974-10-17
PL96883B1 (pl)	1978-01-31
AR204951A1 (es)	1976-03-19
ES447063A1 (es)	1977-06-16
FR2226172A1 (ro)	1974-11-15
CA1034953A (en)	1978-07-18
BG22821A3 (bg)	1977-04-20
ES425373A1 (es)	1976-09-01
RO63749A (fr)	1979-01-15
SU539525A3 (ru)	1976-12-15
DD113757A5 (ro)	1975-06-20
BG21217A3 (bg)	1976-03-20
CH605800A5 (ro)	1978-10-13
HK70276A (en)	1976-11-19
NL177917C (nl)	1985-12-16
BG21218A3 (bg)	1976-03-20
GB1429141A (en)	1976-03-24
AT337176B (de)	1977-06-10
LU69872A1 (ro)	1974-11-28
DK136066B (da)	1977-08-08

Publication	Publication Date	Title
NO155774C (no)	1987-05-27	Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO145382C (no)	1982-03-10	Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater.
NO138805C (no)	1978-11-15	Analogifremgangsmaate for fremstilling av farmakologisk aktive triazolforbindelser
NO142155C (no)	1980-07-09	Fremgangsmaate til fremstilling av orale legemiddelpreparater
NO136793C (no)	1977-11-09	Analogifremgangsm}te til fremstilling av terapeutisk virksomme substituerte 1,2,4-triazolderivater.
NO140854C (no)	1979-11-28	Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptid-amider
NO138565C (no)	1978-09-27	Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO138566C (no)	1978-09-27	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO145056C (no)	1982-01-04	(s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO149281C (no)	1984-03-21	Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO140058C (no)	1979-07-04	Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO138530C (no)	1978-09-20	Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater
NO146865C (no)	1982-12-22	Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO139685C (no)	1979-04-25	Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater
NO140597C (no)	1979-10-03	Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater
NO148644C (no)	1983-11-16	Analogifremgangsmaate til fremstilling av terapeutisk aktive sukkerderivater.
NO141850C (no)	1980-06-04	Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO140978C (no)	1979-12-19	Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO139439C (no)	1979-03-14	Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolon-(5)-forbindelser
SE400551B (sv)	1978-04-03	Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
NO144110C (no)	1981-06-24	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
NO143499C (no)	1981-02-25	Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO137728C (no)	1978-04-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO136408C (no)	1977-08-31	Analogifremgangsm}te for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser
NO140062C (no)	1979-07-04	Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoderivater av pyrazolopyridin-ketoner